Moexipril and left ventricular hypertrophy

References

• AbernethyDRFoxAALStimpelMMoexipril in the treatment of mild to moderate essential hypertension: comparison with sustained release varapamilJ Clin Pharmacol1995357959
   Web of Science ®Google Scholar
• Agabiti-RoseiEAmbrosioniEPirelliEfficacy and tolerability of moexipril and nitrendipine in postmenopausal women with hypertension: MADAM study groupEur J Clin Pharmacol199955185910379633
   PubMed Web of Science ®Google Scholar
• BarfourJAGosKLBenazepril, a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in hypertension and congestive heart failureDrugs19954251139
   Google Scholar
• BrillaCGMaubaraIWeberKTAdvanced hypertensive heart disease in spontaneously hypertensive rats: lisinopril-medicated regression of myocardial fibrosisHypertension199628269748707393
   PubMed Web of Science ®Google Scholar
• ChrysantSGAntihypertensive effectiveness of low dose lisinoprilhydrochlorothiazide combinations: a large multicenter studyArch Intern Med1994154737438147677
   PubMed Web of Science ®Google Scholar
• ChrysantSGPerindopril/hydrochlorothiazide dose combination for the treatment of hypertension: a multicenter studyJ Clin Pharmacol19973747529048272
   PubMed Web of Science ®Google Scholar
• ChrysantSG.Vascular remodeling: the role of angiostensin-converting enzyme inhibitorsAm Heart J1998a135S21S309488609
   PubMed Web of Science ®Google Scholar
• ChrysantSGFixed low-dose drug combination for the treatment of hypertensionArch Fam Med1998b737069682692
   PubMedGoogle Scholar
• ChrysantSGDunnMMarplesDSevere reversible azortemia from captopril therapy: report of three cases and review of the literatureArch Intern Med1983143437416338847
   PubMedGoogle Scholar
• ChrysantSGFoxAALStimpelMComparison of moexipril, a new ACE inhibitor, to varapamil-SR as add-on therapy to low dose hydrochlorothiazide in hypertensive patientsAm J Hypertens19958418217619356
   PubMed Web of Science ®Google Scholar
• ChrysantSGFaganTGlazerREffects of benazepril and hydrochlorothiadize, given alone and in low and high-dose combinations, on blood pressure in patients with hypertensionArch Fam Med1996517248542050
   PubMedGoogle Scholar
• ChrysantSGStimpelMAntihypertensive effectiveness of a very low fixed-dose comination of moexipril and hydrochlorothiazideJ Cardiovasc Pharmacol199831384909514183
   PubMed Web of Science ®Google Scholar
• DahlofBDevereuxRBKjeldsenSECardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomized trial against atenololLancet2002359995100311937178
   PubMed Web of Science ®Google Scholar
• DevereuxRBLeft ventricular geometry, pathophysiology and prognosisJ Am Coll Cardiol19952588577884092
   PubMed Web of Science ®Google Scholar
• DevereuxRBDahlofBGerdtsERegression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the losartan intervention for endpoint reduction in hypertension (LIFE) trialCirculation200411014566215326072
   PubMed Web of Science ®Google Scholar
• DevereuxRBRomanMJInter-relationships between hypertension, left ventricular hypertrophy and coronary heart diseaseJ Hypertens19931139
   Web of Science ®Google Scholar
• DicksteinKAaslandTFerrariPComparison of the efficacy of three dose levels of moexipril versus placebo as add-on therapy to hydrochlorothiazide in patients with moderate hypertensionJ Cardiovasc Pharmacol199424247557526056
   PubMed Web of Science ®Google Scholar
• EdlingOBaoGFeelischMMoexipril, a new angiotensin converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalaprilJ Pharmacol Exp Ther1995275854637473177
   PubMed Web of Science ®Google Scholar
• FrohlichEDApsteinCChobanianAVThe heart in hypertensionN Engl J Med199232799810081518549
   PubMed Web of Science ®Google Scholar
• FroshlichEDHorinakSCardiac and aortic effects of angiotensin converting enzyme inhibitorsHypertension199118Suppl II27
   Google Scholar
• GhaliJKLiaoYCooperRSInfluence of left ventricular geometric patterns on prognosis in patients with or without coronary artery diseaseJ Am Coll Cardiol1998311635409626845
   PubMed Web of Science ®Google Scholar
• GhaliJKLiaoYSimmonsBThe prognostic role of left ventricular hypertrophy in patients with or without coronary artery diseaseAnn Intern Med199211783161416558
   PubMed Web of Science ®Google Scholar
• GottdienerJSRedaDJMassieBMEffect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertensionCirculation1997952007149133508
   PubMed Web of Science ®Google Scholar
• GrassGMMoreheadWEvidence for site specific absorption of a nove ACE inhibitorPharm Res19896759652554270
   PubMed Web of Science ®Google Scholar
• GroheCKahlertSLobbertKEffects of moexiprilat on estrogen-stimulated cardiac fibroblast growthBr J Pharmacol1997121159146879
   PubMed Web of Science ®Google Scholar
• HaiderAWLarsonMGBenjaminEJIncreased left ventricular mass and hypertrophy are associated with increased risk for sudden deathJ Am Coll Cardiol1998321454629809962
   PubMed Web of Science ®Google Scholar
• HoefleMLKlutchkoS.Substituted acyl derivatives of 1, 2, 3, 4 tetrahydroquinoline 3-carboxylic acidsUS Pat19829449
   Google Scholar
• KnutsenRKnutsenSCurbJDThe predictive value of resting electrocardiograms for 12-year incidence of coronary heart disease in the Honolulu Heart ProgramJ Clin Epidemiol1988412933023339383
   PubMed Web of Science ®Google Scholar
• KorenMJDevereuxRBCasalePNRelation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertensionAnn Intern Med1991114345521825164
   PubMed Web of Science ®Google Scholar
• KrumholzHMLarsonMLevyDPrognosis of left ventricular geometric patterns in the Framingham Heart StudyJ Am Coll Cardiol199525879847884091
   PubMed Web of Science ®Google Scholar
• KlucthkoSBlankelyCJFlemingRWSynthesis of the novel angiotensin converting enzyme inhibitor quinapril and related compounds. A divergence of structure-activity relationship for non-sulfhydryl and sulfhydryl typesJ Med. Chem19862919539613020249
   PubMed Web of Science ®Google Scholar
• LancasterSGToddPAMoexipril: a preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in hypertension and congestive heart failureDrugs199835646672844497
   PubMedGoogle Scholar
• LevyDAndersonKMSavageDDEchocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart StudyAnn Intern Med19881087132962527
   PubMed Web of Science ®Google Scholar
• LevyDSalomonMD’AgostinoRBPrognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophyCirculation1994901786937923663
   PubMed Web of Science ®Google Scholar
• LiebsonPRGranditsGADianzumbaSComparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS)Circulation1995916987067828296
   PubMed Web of Science ®Google Scholar
• LucasCDDargaLLFoxAALA study of the efficacy and safety of moexipril in mild to moderate hypertensionAm J Ther199528869211854803
   PubMedGoogle Scholar
• MoserMHebertPRPrevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trialsJ Am Coll Cardiol1996271214188609345
   PubMed Web of Science ®Google Scholar
• NeatonJDGrimmRJJrStamlerJTreatment of Mild Hypertension Study Research Group. Treatment of Mild Hypertension Study: final resultsJAMA1993270713248336373
   PubMed Web of Science ®Google Scholar
• PerssonBStimpelMEvaluation of the antihypertensive efficacy and tolerability of moexipril, a new ACE inhibitor, compared to hydrochlorothiazide in elderly patientsEur J Clin Pharmacol199650259648803515
   PubMed Web of Science ®Google Scholar
• PfefferMABraunwaldEMoyeLAEffect of captopril on morality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE InvestigatorsN Engl J Med1992327669771386652
   PubMed Web of Science ®Google Scholar
• PhillipsRADiamondJAOparilSWeberMALeft ventricular hypertrophy, congestive heart failure, and coronary flow reserve abnormalities in hypertensionHypertension: A Companion to Brenner and Rector’s The Kidney1999PhiladelphiaW.B. Saunders Company24477
   Google Scholar
• RosendorffCThe rennin-angiotensin system and vascular hypertrophyJ Am Coll Cardiol199628803128837552
   PubMed Web of Science ®Google Scholar
• RumbleJRKomersRCooperMEKinins or nitric oxide, or both are involved in the antitrophic effects of angiotensin converting enzyme inhibitors on diabetes-associated mesenteric vascular hypertrophy in the ratJ Hypertens19961460178762203
   PubMed Web of Science ®Google Scholar
• The SOLVD InvestigatorsEffects on enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failureN Engl J Med19913252933022057034
   PubMed Web of Science ®Google Scholar
• SayeghFTopouchianJHlawatyMRegression of left ventricular hypertrophy with moexipril, an angiotensin-converting enzyme inhibitor, in hypertensive patientsAm J Ther2005123815662286
   PubMedGoogle Scholar
• SchlaichMPSchmiederRELeft ventricular hypertrophy and its regression: pathophysiology and therapeutic approachJ Hypertens1998111394404
   Web of Science ®Google Scholar
• SchmiederREMartusPKlingbeilAReversal of left ventricular hypertrophy in essential hypertensionJAMA19962751507138622227
   PubMed Web of Science ®Google Scholar
• SinghviSMDuchinKCMorrisonRADisposition of fosinopril sodium in healthy subjectsBr J Clin Pharmacol1998259152967089
   PubMedGoogle Scholar
• SongJCWhiteCMClinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors. An updateClin Pharmacokinet2002412072411929321
   PubMed Web of Science ®Google Scholar
• SpinarJVitovecJMORE-moexipril and regression of left ventricular hypertrophy in combination therapy. A multicentric open label clinical trialInt J Cardiol200510019920615823625
   PubMed Web of Science ®Google Scholar
• StimpelMBonnRKochBKPharmacology and clinical use of the new ACE inhibitor moexiprilCardiovasc Drug Rev19951321129
   Google Scholar
• StimpelMKochBAntihypertensive treatment in postmenopausal women with hypertension and obesity: moexipril versus atenolol [abstract]Am J Hypertens19969175A
   Google Scholar
• StimpelMKochBJansenTMoexrpril versus captopril in patients with mild to moderate hypertensionJ Cardiovasc Pharmacol1996a28769738961074
   PubMed Web of Science ®Google Scholar
• StimpelMKochBDicksteinKMoexipril as add-on therapy to hydrochlorothiazide in moderate to severe hypertensionCardiology1996b87313188793166
   PubMed Web of Science ®Google Scholar
• StimpelMKochBAntihypertensive treatment with moexipril plus HCTZ vs. metrprolol plus HCTZ in patients with mild to moderate hypertensionJ Hum Hypertens19971113379140801
   PubMed Web of Science ®Google Scholar
• StimpelMKochBOparilSAntihypertensive treatment in postmenopausal women: results from a prospective, randomized, double blind, controlled study comparing an ACE inhibitor (moexipril) with a diuretic (hydrochlorothiazide)Cardiology19988927169643274
   PubMed Web of Science ®Google Scholar
• StimpelMKochBWeberMAComparison between moexipril and atenolol in obese postmenopausal women with hypertensionMaturitas19983069779819786
   PubMed Web of Science ®Google Scholar
• StraussHMZhuYCRedlichTAngiotensin-converting enzyme inhibition in infarct-induced heart failure in rats: bradykinin versus angiotensin IIJ Cardiovasc Risk19941255627621306
   PubMedGoogle Scholar
• ThurmannPAKenediPSchmidtAInfluence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertensionCirculation1998982037429808602
   PubMed Web of Science ®Google Scholar
• VerdecchiaPSchillaciGBorgioniCAdverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular massJ Am Coll Cardiol199525879847884091
   PubMed Web of Science ®Google Scholar
• VerdecchiaPSchillaciGBorgioniCPrognostic significance of serial changes in left ventricular mass in essential hypertensionCirculation19989748549443431
   PubMed Web of Science ®Google Scholar
• WhiteWBFoxAALStimpelMLong term efficacy and safety of moexipril in the treatment of hypertensionJ Hum Hypertens199489179217884791
   PubMed Web of Science ®Google Scholar
• WhiteWBKochBStimpelMUsefulness of moexipril and hydrochlorothiazide in moderately severe essential hypertensionAm J Ther19974123910423601
   PubMedGoogle Scholar
• WhiteWBStimpelMLong-term efficacy and safety of moexipril alone and in combination with hydrochlorothiazide in elderly patients with hypertensionJ Hum Hypertens19959879848583466
   PubMed Web of Science ®Google Scholar